Level A Evidence
6 Treatment Options Available

Heart Transplant

Heart transplantation for end-stage heart failure with ventricular assist device bridging

Heart transplantation remains the gold standard treatment for end-stage heart failure when medical therapy and mechanical support are no longer effective. Chinese heart transplant centers have developed comprehensive programs including ventricular assist device (VAD) bridging, total artificial heart support, and advanced immunosuppression protocols. With experienced cardiac surgeons and specialized post-transplant care teams, these centers achieve outcomes comparable to international standards.

JCI Accredited
90%+ 1-Year Survival
Living & Deceased Donor

Condition Overview

Conditions We Treat

Dilated CardiomyopathyIschemic CardiomyopathyCongenital Heart Disease (adult)Restrictive CardiomyopathyHypertrophic Cardiomyopathy (end-stage)Ventricular Assist Device (VAD) BridgeRe-transplantation

Core Technologies

Bicaval anastomosis technique • VAD bridging (LVAD/RVAD/BiVAD) • Total artificial heart • ECMO support • Advanced immunosuppression • Cardiac rehabilitation • Remote monitoring

适宜人群

  • •End-stage heart failure (NYHA Class IV)
  • •Life expectancy <1 year without transplant
  • •No irreversible organ damage (excluding heart)
  • •No active infections or recent malignancy
  • •Psychologically stable with social support
  • •BMI <35 (or willing to reduce)

Age typically under 70, but individualized assessment for older patients

建议在本地考虑

  • •Patients already on VAD support requiring close monitoring
  • •Those with significant pulmonary hypertension
  • •Combined heart-lung transplant candidates
  • •Patients with complex congenital heart disease

Evidence: 1-year survival rates of 85-90%, 5-year survival of 70-75% in experienced centers. VAD as bridge to transplant improves outcomes for critically ill patients. Chinese heart transplant outcomes align with international registry data.

Treatment Options

Orthotopic Heart Transplant

手术
适合：Standard heart transplant candidates
技术：Bicaval technique with preservation of right atrial anatomy
优势：Gold standard, established technique
Surgery 4-6 hours, ICU 5-10 daysFrom $100,000
Most common procedure

VAD as Bridge to Transplant

手术
适合：Critically ill awaiting transplant
技术：LVAD, RVAD, or BiVAD implantation
优势：Stabilizes patient, improves transplant outcomes
Implantation + eventual transplantFrom $150,000 total
Increasing utilization

High-Urgency Transplant

手术
适合：Critical status (ECMO, deteriorating VAD)
技术：Expedited listing and transplantation
优势：Life-saving for critically ill
Variable based on organ availabilityFrom $120,000
Priority allocation system

Heart Re-transplantation

手术
适合：Graft failure, severe coronary allograft vasculopathy
技术：Removal of failed graft, new transplantation
优势：Only option for graft failure
Surgery 5-8 hoursFrom $120,000
Specialized procedure, higher risk

Mechanical Circulatory Support

手术
适合：Bridge to decision, bridge to recovery
技术：ECMO, Impella, temporary VAD
优势：Short-term support for acute failure
Days to weeksFrom $50,000
Available in major centers

Heart Transplant Care Program

药物
适合：All heart transplant recipients
技术：Immunosuppression, rejection monitoring, rehabilitation
优势：Essential for long-term survival
LifelongFrom $1,000/month
Structured surveillance programs

费用对比

Heart Transplant (Including 1-Year Follow-up)

US Transplant Center$1,300,000
UK NHS/Private$250,000
MediLink China$120,000

Save 91% vs US • Includes: surgery, hospital stay, ICU, immunosuppression, cardiac rehabilitation, 1-year follow-up. VAD bridge additional.

计算费用

治疗流程

1
Evaluation• 1-2 weeks
  • Comprehensive cardiac evaluation
  • Right heart catheterization
  • Pulmonary function testing
  • Infection and malignancy screening
  • Psychosocial assessment
2
Transplant• Week of surgery
  • Organ procurement coordination
  • Heart transplant surgery
  • ICU recovery and ventilation weaning
  • Immunosuppression initiation
  • Early mobilization
3
Recovery• Months 1-6
  • Intensive cardiac rehabilitation
  • Rejection surveillance (biopsies)
  • Infection prophylaxis
  • Medication optimization
  • Gradual return to activities

Clinical Outcomes

1-Year Survival
85-90%
overall
5-Year Survival
70-75%
overall
Median Survival
13-15 years
post-transplant
Rejection Rate
20-30%
first year (treatable)

常见问题

What is the wait time for a heart transplant?
Wait times vary based on blood type, size match, and medical urgency. High-urgency patients on mechanical support receive priority. Your transplant team will discuss expected timeframes based on your status.
What is a VAD and do I need one?
A Ventricular Assist Device (VAD) is a mechanical pump that supports heart function. It may be needed as a "bridge" to transplant if your heart is too weak to wait, or as "destination therapy" if transplant is not an option.
How long can a transplanted heart last?
Median survival is about 13-15 years, with many patients living 20+ years. Longevity depends on age at transplant, underlying disease, rejection episodes, and development of cardiac allograft vasculopathy.
Will I need cardiac rehabilitation?
Yes, comprehensive cardiac rehabilitation is essential post-transplant. It begins in the hospital and continues for months, helping you regain strength and return to normal activities safely.

Important Information

Organ transplantation involves complex medical, ethical, and legal considerations. China operates a voluntary citizen organ donation system based on deceased donation after death, established in 2015. Eligibility for foreign patients depends on multiple factors including medical urgency, donor availability, and current regulations. Please contact us for current eligibility criteria and program availability.

Learn More About Transplant Options

Get information about transplant evaluation, eligibility, and care pathways.

咨询Email Your Questions

Other Transplant Programs

Kidney Transplant
6 options
Liver Transplant
6 options
Lung Transplant
6 options
返回概览